MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0044587
Eekshana Pharmaceuticals Private Limited
Eekshana Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.02 Cr
▲ 43% YoY
Net profit · FY 2024
₹4.7 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹7.87 Lakh
EBITDA margin 2.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Eekshana Pharmaceuticals Private Limited
Data last updated:
Eekshana Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2016PTC103602. Its GSTIN is 36AAECE2184N1ZB (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venu Madhav Nallapati and Ramanjaneyulu Bajantri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tirumala Towers H.No.16 – 2 – 677/2 Inward No:16 Block No.2 Judges Colony Malakpet, Hyderabad, Telangana, India – 500036.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.02 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹4.7 Lakh (net margin 1.6%) and EBITDA of ₹7.87 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 6% over five years.
Eekshana Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0044587). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2016PTC103602
Registration Number 103602
Incorporation Date 02 March 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0044587
Recognitions & Rankings of Eekshana Pharmaceuticals
Contact details
Eekshana Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTirumala Towers H.No.16 – 2 – 677/2 Inward No:16 Block No.2 Judges Colony Malakpet, Hyderabad, Telangana, India – 500036
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eekshana Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Eekshana Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eekshana Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eekshana Pharmaceuticals Private Limited, buy the company report.
Financials of Eekshana Pharmaceuticals Private Limited
FY 2025 filings availableEekshana Pharmaceuticals Private Limited reported revenue of ₹3.02 Cr (up 43% YoY) for FY 2024.
Revenue · FY 2024
₹3.02 Cr ▲ 43%
Net profit · FY 2024
₹4.7 Lakh margin 1.6%
EBITDA · FY 2024
₹7.87 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 16%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 8%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 43% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eekshana Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eekshana Pharmaceuticals Private Limited
Eekshana Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venu Madhav Nallapati Also directs: Oxygen Pharma Care Private Limited | Director | 01 Apr 2021 | 5 Years 6 Months | Current |
| Ramanjaneyulu Bajantri Also directs: Oxygen Pharma Care Private Limited | Director | 02 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Eekshana Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arhy Export Private Limited | ₹3.02 Cr (FY 2018) | -41.0% | Mumbai, Maharashtra, India | |||
| Maaxmus Life Sciences Private Limited | ₹3.02 Cr (FY 2024) | 13.0% | Chennai, Tamil Nadu, India | |||
| Eekshana Pharmaceuticals Private Limitedthis company | ₹3.02 Cr (FY 2024) | ₹4.7 Lakh | 1.6% | 43.0% | Hyderabad, Telangana, India | |
| Semiotic Pharmaceutical Private Limited | ₹3.01 Cr (FY 2025) | -18.0% | Bhubaneswar, Odisha, India | |||
| Maple Health Care Private Limited | ₹3.01 Cr (FY 2022) | 1405.0% | Coimbatore, Tamil Nadu, India | |||
| Evershine Lifesciences Private Limited | ₹3 Cr (FY 2025) | -12.0% | Chandigarh, India |
To see the full peer comparison of Eekshana Pharmaceuticals Private Limited, buy the company report.
Auditor
Eekshana Pharmaceuticals Private Limited is audited by B K S KUMAR & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K S KUMAR & CO | FY 2020 | 007769S |
Shareholding
The shareholding of Eekshana Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Eekshana Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eekshana Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eekshana Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eekshana Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECE2184N1ZB | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eekshana Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eekshana Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Venu Madhav Nallapati ceased to be Additional Director on 30 Nov 2021.
AGM
Eekshana Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eekshana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Venu Madhav Nallapati ceased to be Additional Director.
Ceased
Harinath Badam ceased to be Director.
Appointed
Venu Madhav Nallapati was appointed as Director.
Appointed
Ramanjaneyulu Bajantri was appointed as Director.
Incorporation
02 Mar 2016
Eekshana Pharmaceuticals Private Limited was registered on 02 Mar 2016 with Roc Hyderabad & aged 10 years 7 months as per MCA records.
Frequently asked questions
Eekshana Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 2016 (10+ years old) and is registered under CIN U24100TG2016PTC103602.
Eekshana Pharmaceuticals has 2 current directors:
- Venu Madhav Nallapati - Director
- Ramanjaneyulu Bajantri - Director
The latest financial statements of Eekshana Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Eekshana Pharmaceuticals is 36AAECE2184N1ZB, registered in Telangana.
The CIN (Corporate Identification Number) of Eekshana Pharmaceuticals is U24100TG2016PTC103602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eekshana Pharmaceuticals was incorporated on 02 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Eekshana Pharmaceuticals by revenue are Arhy Export Private Limited, Maaxmus Life Sciences Private Limited, Semiotic Pharmaceutical Private Limited, Maple Health Care Private Limited, Evershine Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Venu Madhav Nallapati ceased to be Additional Director on 30 Nov 2021. Harinath Badam ceased to be Director on 15 Apr 2021. Venu Madhav Nallapati was appointed as Director on 01 Apr 2021. Eekshana Pharmaceuticals has 4 board changes on record in total.
Yes, Eekshana Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0044587).
The registered office of Eekshana Pharmaceuticals is at Tirumala Towers H.No.16 – 2 – 6772 Inward No:16 Block No.2 Judges Colony Malakpet, Hyderabad, Telangana, India – 500036.
Eekshana Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.